ArtsAutosBooksBusinessEducationEntertainmentFamilyFashionFoodGamesGenderHealthHolidaysHomeHubPagesPersonal FinancePetsPoliticsReligionSportsTechnologyTravel

How Quickly Can We Treat COVID-19?

Updated on August 24, 2020
Source

Producing a vaccine in 18 months would make it the fastest vaccine developed in history. While 18 months may seem like a long time, usually, vaccinations take up to a decade or more to be approved and licensed for global use. So how are scientists able to produce a vaccine in just 18 months and still, why would it take that long?

Vaccinations take a long time to develop, and with good reason. Is it realistic to expect a coronavirus vaccine in 18 months? It may seem like a long time but if scientists do manage to create a vaccine in 18 months, that would be the fastest vaccine developed in human history. It would be unprecedented like the virus itself.


How do vaccines work?

Vaccines present part or all of the pathogen (the agent that cause the disease) in a weakened version (or dead version) to the human immune system, usually in the form of an injection. These parts that are presented into our system via injections are markers called antigens. These markers trigger the system to produce antibodies to the pathogen. Our immune system is able to recognise these markers as an intruder, and forms antibodies, allowing it to “remember” the pathogen in case it tries to infect you in the future. These antibodies remain in the body and are ready to react if an actual infectious organism attack.


“Vaccines tricks the body into thinking it is under assault, and the immune system makes weapons that will provide a defence when a real infection becomes a threat.” — American Academy of Paediatricians.


Vaccinations usually take up to a decade or more to be approved and licensed for global use.


But…


We have an edge

The main reason we may be able to achieve the 18-month target is that COVID-19 is part of the coronavirus group. Previous pandemics involving coronaviruses include the Severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) outbreaks.


COVID-19 (Sars-CoV-2) shares around 80% of the same genetic material as SARS, and around 50% of the same material as MERS. A lot of study and research has already been done on these two viruses. So we do have a head start in creating a COVID-19 vaccine.


Both viruses contain ribonucleic acid (RNA) capsule that is covered in spikes. The spikes attach on to receptors on the surface of cells lining the human airways allowing the virus to break into the cell. (Read: How COVID-19 Attacks Your Body)

Even with this head start, there is a lot of work to be done.


Clinical trials

Most vaccine developers would do animal testing first before moving on to human trials.

But, a new coronavirus trial in the US — the Moderna trial — has skipped the animal testing phase and gone straight to human testing in order to speed up the process.

However, even without animal testing, there are still several processes that need to be followed in human trials. There are four phases:

Credits: https://www.researchgate.net/figure/Characteristics-of-Clinical-Trial-Phases_tbl4_301745695


Not the perfect vaccine, yet

After the final phase (phase four) the manufacturer may apply for a licence to market the vaccine. The research also undergoes a review by experts at this point.

“The development of the COVID-19 vaccine is being fast-tracked as much as possible given the urgent demand for it. But even though we may already be at a stage where it has been manufactured and can undergo trials on humans, it is still likely to take 12 to 18 months before it is available worldwide for public health use, as safety cannot be compromised.

This, however, is a new disease that we are still only starting to scratch the surface of, and more information is needed from further modelling and studies of the virus.

It is for this reason that both the safety and efficacy of a vaccine must be assessed through all phases of a trial, without cutting corners.” — Dr Sara Kayat on Al Jazeera News.

Comments

    0 of 8192 characters used
    Post Comment

    No comments yet.

    working

    This website uses cookies

    As a user in the EEA, your approval is needed on a few things. To provide a better website experience, hubpages.com uses cookies (and other similar technologies) and may collect, process, and share personal data. Please choose which areas of our service you consent to our doing so.

    For more information on managing or withdrawing consents and how we handle data, visit our Privacy Policy at: https://corp.maven.io/privacy-policy

    Show Details
    Necessary
    HubPages Device IDThis is used to identify particular browsers or devices when the access the service, and is used for security reasons.
    LoginThis is necessary to sign in to the HubPages Service.
    Google RecaptchaThis is used to prevent bots and spam. (Privacy Policy)
    AkismetThis is used to detect comment spam. (Privacy Policy)
    HubPages Google AnalyticsThis is used to provide data on traffic to our website, all personally identifyable data is anonymized. (Privacy Policy)
    HubPages Traffic PixelThis is used to collect data on traffic to articles and other pages on our site. Unless you are signed in to a HubPages account, all personally identifiable information is anonymized.
    Amazon Web ServicesThis is a cloud services platform that we used to host our service. (Privacy Policy)
    CloudflareThis is a cloud CDN service that we use to efficiently deliver files required for our service to operate such as javascript, cascading style sheets, images, and videos. (Privacy Policy)
    Google Hosted LibrariesJavascript software libraries such as jQuery are loaded at endpoints on the googleapis.com or gstatic.com domains, for performance and efficiency reasons. (Privacy Policy)
    Features
    Google Custom SearchThis is feature allows you to search the site. (Privacy Policy)
    Google MapsSome articles have Google Maps embedded in them. (Privacy Policy)
    Google ChartsThis is used to display charts and graphs on articles and the author center. (Privacy Policy)
    Google AdSense Host APIThis service allows you to sign up for or associate a Google AdSense account with HubPages, so that you can earn money from ads on your articles. No data is shared unless you engage with this feature. (Privacy Policy)
    Google YouTubeSome articles have YouTube videos embedded in them. (Privacy Policy)
    VimeoSome articles have Vimeo videos embedded in them. (Privacy Policy)
    PaypalThis is used for a registered author who enrolls in the HubPages Earnings program and requests to be paid via PayPal. No data is shared with Paypal unless you engage with this feature. (Privacy Policy)
    Facebook LoginYou can use this to streamline signing up for, or signing in to your Hubpages account. No data is shared with Facebook unless you engage with this feature. (Privacy Policy)
    MavenThis supports the Maven widget and search functionality. (Privacy Policy)
    Marketing
    Google AdSenseThis is an ad network. (Privacy Policy)
    Google DoubleClickGoogle provides ad serving technology and runs an ad network. (Privacy Policy)
    Index ExchangeThis is an ad network. (Privacy Policy)
    SovrnThis is an ad network. (Privacy Policy)
    Facebook AdsThis is an ad network. (Privacy Policy)
    Amazon Unified Ad MarketplaceThis is an ad network. (Privacy Policy)
    AppNexusThis is an ad network. (Privacy Policy)
    OpenxThis is an ad network. (Privacy Policy)
    Rubicon ProjectThis is an ad network. (Privacy Policy)
    TripleLiftThis is an ad network. (Privacy Policy)
    Say MediaWe partner with Say Media to deliver ad campaigns on our sites. (Privacy Policy)
    Remarketing PixelsWe may use remarketing pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to advertise the HubPages Service to people that have visited our sites.
    Conversion Tracking PixelsWe may use conversion tracking pixels from advertising networks such as Google AdWords, Bing Ads, and Facebook in order to identify when an advertisement has successfully resulted in the desired action, such as signing up for the HubPages Service or publishing an article on the HubPages Service.
    Statistics
    Author Google AnalyticsThis is used to provide traffic data and reports to the authors of articles on the HubPages Service. (Privacy Policy)
    ComscoreComScore is a media measurement and analytics company providing marketing data and analytics to enterprises, media and advertising agencies, and publishers. Non-consent will result in ComScore only processing obfuscated personal data. (Privacy Policy)
    Amazon Tracking PixelSome articles display amazon products as part of the Amazon Affiliate program, this pixel provides traffic statistics for those products (Privacy Policy)
    ClickscoThis is a data management platform studying reader behavior (Privacy Policy)